Found 66 matching trials
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors PHASE1 This clinical study is to investigate the safety and tolerability of CAR mo...
Show More Location
Shanghai Zhongshan Hospital
Learn More & Join Trial
EX02 CAR-T Cells for Relapsed and Refractory Acute Myeloid Leukemia EARLY_PHASE1 This is a early Phase 1 open-label, single-arm clinical study of EX02 CAR-T...
Show More Location
The Second Affliated Hospital of Anhui Medical University
Learn More & Join Trial
Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease PHASE1 ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy de...
Show More Learn More & Join Trial
BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease PHASE1 Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated act...
Show More Location
Boston Children's Hospital
Learn More & Join Trial
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). PHASE3 The purpose of this study is to measure the efficacy of AZD0120 compared wi...
Show More Learn More & Join Trial
Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This is a single arm, open-label, dose escalation clinical study to evaluat...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Intravenous Autologous CD19 CAR-T Cells for R/R B-ALL PHASE2 This is Phase II / III, Prospective, single arm, Open Label Study to Evalua...
Show More Location
UKM Medical Centre
Learn More & Join Trial
RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies PHASE1 This is an open-label Phase 1 study to determine the feasibility, safety, a...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis PHASE1 A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects w...
Show More Location
Stanford Multiple Sclerosis Center
Learn More & Join Trial
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis PHASE2 A Study of the Anti-CD 19 Chimeric Antigen Receptor T Cell Therapy for Pati...
Show More Location
Ronald Reagan UCLA Medical Center
Learn More & Join Trial